These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8701590

  • 1. Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months.
    Böttiger M.
    Vaccine; 1995 Dec; 13(18):1759-62. PubMed ID: 8701590
    [Abstract] [Full Text] [Related]

  • 2. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme.
    Broliden K, Levén B, Arneborn M, Böttiger M.
    Scand J Infect Dis; 1998 Dec; 30(1):23-7. PubMed ID: 9670354
    [Abstract] [Full Text] [Related]

  • 3. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme.
    Broliden K, Abreu ER, Arneborn M, Böttiger M.
    Vaccine; 1998 Dec; 16(2-3):323-7. PubMed ID: 9607050
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
    Christenson B, Böttiger M.
    Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Boosting effect of a second dose of measles vaccine given to 12-year-old children.
    Böttiger M.
    Scand J Infect Dis; 1993 May; 25(2):239-43. PubMed ID: 8511518
    [Abstract] [Full Text] [Related]

  • 12. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G, Peña B, Marimón JM, Pérez-Trallero E.
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [Abstract] [Full Text] [Related]

  • 13. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up.
    Davidkin I, Valle M, Julkunen I.
    Vaccine; 1995 Nov; 13(16):1617-22. PubMed ID: 8578851
    [Abstract] [Full Text] [Related]

  • 14. Previous exposure to measles, mumps, and rubella--but not vaccination during adolescence--correlates to the prevalence of pancreatic and thyroid autoantibodies.
    Lindberg B, Ahlfors K, Carlsson A, Ericsson UB, Landin-Olsson M, Lernmark A, Ludvigsson J, Sundkvist G, Ivarsson SA.
    Pediatrics; 1999 Jul; 104(1):e12. PubMed ID: 10390298
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K, Nicoara C, Germann D, Matter L.
    Schweiz Med Wochenschr; 1998 Apr 25; 128(17):649-57. PubMed ID: 9622837
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts.
    Davidkin I, Valle M.
    Vaccine; 1998 Dec 25; 16(20):2052-7. PubMed ID: 9796064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.